2-bromo-6-(2-tert-butyl-4-pyridinyl)pyridine;4-[6-(2-tert-butyl-4-pyridinyl)-2-pyridinyl]-3-chlorobenzoic acid;[4-[6-(2-tert-butyl-4-pyridinyl)-2-pyridinyl]-3-chlorophenyl]-(4-hydroxypiperidin-1-yl)methanone;2-tert-butyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine;(2-chloro-4-formyloxyphenyl)boronic acid;2,6-dibromopyridine;piperidin-4-ol

C93H106B2Br3Cl3N10O11 — CID 159956586

IUPAC2-bromo-6-(2-tert-butyl-4-pyridinyl)pyridine;4-[6-(2-tert-butyl-4-pyridinyl)-2-pyridinyl]-3-chlorobenzoic acid;[4-[6-(2-tert-butyl-4-pyridinyl)-2-pyridinyl]-3-chlorophenyl]-(4-hydroxypiperidin-1-yl)methanone;2-tert-butyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine;(2-chloro-4-formyloxyphenyl)boronic acid;2,6-dibromopyridine;piperidin-4-ol
SMILESBrc1cccc(Br)n1.CC(C)(C)c1cc(-c2cccc(-c3ccc(C(=O)N4CCC(O)CC4)cc3Cl)n2)ccn1.CC(C)(C)c1cc(-c2cccc(-c3ccc(C(=O)O)cc3Cl)n2)ccn1.CC(C)(C)c1cc(-c2cccc(Br)n2)ccn1.CC(C)(C)c1cc(B2OC(C)(C)C(C)(C)O2)ccn1.O=COc1ccc(B(O)O)c(Cl)c1.OC1CCNCC1
InChIInChI=1S/C26H28ClN3O2.C21H19ClN2O2.C15H24BNO2.C14H15BrN2.C7H6BClO4.C5H3Br2N.C5H11NO/c1-26(2,3)24-16-17(9-12-28-24)22-5-4-6-23(29-22)20-8-7-18(15-21(20)27)25(32)30-13-10-19(31)11-14-30;1-21(2,3)19-12-13(9-10-23-19)17-5-4-6-18(24-17)15-8-7-14(20(25)26)11-16(15)22;1-13(2,3)12-10-11(8-9-17-12)16-18-14(4,5)15(6,7)19-16;1-14(2,3)12-9-10(7-8-16-12)11-5-4-6-13(15)17-11;9-7-3-5(13-4-10)1-2-6(7)8(11)12;6-4-2-1-3-5(7)8-4;7-5-1-3-6-4-2-5/h4-9,12,15-16,19,31H,10-11,13-14H2,1-3H3;4-12H,1-3H3,(H,25,26);8-10H,1-7H3;4-9H,1-3H3;1-4,11-12H;1-3H;5-7H,1-4H2
InChIKeyOCUGQMRACBJKQO-UHFFFAOYSA-N
MW1907.62 g/mol
LogP19.59
Rot. Bonds11

About 2-bromo-6-(2-tert-butyl-4-pyridinyl)pyridine;4-[6-(2-tert-butyl-4-pyridinyl)-2-pyridinyl]-3-chlorobenzoic acid;[4-[6-(2-tert-butyl-4-pyridinyl)-2-pyridinyl]-3-chlorophenyl]-(4-hydroxypiperidin-1-yl)methanone;2-tert-butyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine;(2-chloro-4-formyloxyphenyl)boronic acid;2,6-dibromopyridine;piperidin-4-ol

2-bromo-6-(2-tert-butyl-4-pyridinyl)pyridine;4-[6-(2-tert-butyl-4-pyridinyl)-2-pyridinyl]-3-chlorobenzoic acid;[4-[6-(2-tert-butyl-4-pyridinyl)-2-pyridinyl]-3-chlorophenyl]-(4-hydroxypiperidin-1-yl)methanone;2-tert-butyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine;(2-chloro-4-formyloxyphenyl)boronic acid;2,6-dibromopyridine;piperidin-4-ol (PubChem CID 159956586) has the molecular formula C93H106B2Br3Cl3N10O11 and a molecular weight of 1907.62 g/mol. Its IUPAC name is 2-bromo-6-(2-tert-butyl-4-pyridinyl)pyridine;4-[6-(2-tert-butyl-4-pyridinyl)-2-pyridinyl]-3-chlorobenzoic acid;[4-[6-(2-tert-butyl-4-pyridinyl)-2-pyridinyl]-3-chlorophenyl]-(4-hydroxypiperidin-1-yl)methanone;2-tert-butyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine;(2-chloro-4-formyloxyphenyl)boronic acid;2,6-dibromopyridine;piperidin-4-ol.

Molecular Properties

Compound Name2-bromo-6-(2-tert-butyl-4-pyridinyl)pyridine;4-[6-(2-tert-butyl-4-pyridinyl)-2-pyridinyl]-3-chlorobenzoic acid;[4-[6-(2-tert-butyl-4-pyridinyl)-2-pyridinyl]-3-chlorophenyl]-(4-hydroxypiperidin-1-yl)methanone;2-tert-butyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine;(2-chloro-4-formyloxyphenyl)boronic acid;2,6-dibromopyridine;piperidin-4-ol
PubChem CID159956586
Molecular FormulaC93H106B2Br3Cl3N10O11
Molecular Weight1907.62 g/mol
Exact Mass1902.48
IUPAC Name2-bromo-6-(2-tert-butyl-4-pyridinyl)pyridine;4-[6-(2-tert-butyl-4-pyridinyl)-2-pyridinyl]-3-chlorobenzoic acid;[4-[6-(2-tert-butyl-4-pyridinyl)-2-pyridinyl]-3-chlorophenyl]-(4-hydroxypiperidin-1-yl)methanone;2-tert-butyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine;(2-chloro-4-formyloxyphenyl)boronic acid;2,6-dibromopyridine;piperidin-4-ol
SMILESBrc1cccc(Br)n1.CC(C)(C)c1cc(-c2cccc(-c3ccc(C(=O)N4CCC(O)CC4)cc3Cl)n2)ccn1.CC(C)(C)c1cc(-c2cccc(-c3ccc(C(=O)O)cc3Cl)n2)ccn1.CC(C)(C)c1cc(-c2cccc(Br)n2)ccn1.CC(C)(C)c1cc(B2OC(C)(C)C(C)(C)O2)ccn1.O=COc1ccc(B(O)O)c(Cl)c1.OC1CCNCC1
InChIInChI=1S/C26H28ClN3O2.C21H19ClN2O2.C15H24BNO2.C14H15BrN2.C7H6BClO4.C5H3Br2N.C5H11NO/c1-26(2,3)24-16-17(9-12-28-24)22-5-4-6-23(29-22)20-8-7-18(15-21(20)27)25(32)30-13-10-19(31)11-14-30;1-21(2,3)19-12-13(9-10-23-19)17-5-4-6-18(24-17)15-8-7-14(20(25)26)11-16(15)22;1-13(2,3)12-10-11(8-9-17-12)16-18-14(4,5)15(6,7)19-16;1-14(2,3)12-9-10(7-8-16-12)11-5-4-6-13(15)17-11;9-7-3-5(13-4-10)1-2-6(7)8(11)12;6-4-2-1-3-5(7)8-4;7-5-1-3-6-4-2-5/h4-9,12,15-16,19,31H,10-11,13-14H2,1-3H3;4-12H,1-3H3,(H,25,26);8-10H,1-7H3;4-9H,1-3H3;1-4,11-12H;1-3H;5-7H,1-4H2
InChIKeyOCUGQMRACBJKQO-UHFFFAOYSA-N
XLogP19.59
TPSA298.44 Ų
H-Bond Donors6
H-Bond Acceptors19
Rotatable Bonds11
Heavy Atoms122
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001907.62
LogP ≤ 519.59
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 1019

Computed Properties (RDKit)

Structural Alerts{'alert_name': '2-halo_pyridine', 'substructure': 'N/A'}, {'alert_name': 'aldehyde', 'substructure': 'N/A'}, {'alert_name': 'heavy_metal', 'substructure': 'N/A'}

Analyze 2-bromo-6-(2-tert-butyl-4-pyridinyl)pyridine;4-[6-(2-tert-butyl-4-pyridinyl)-2-pyridinyl]-3-chlorobenzoic acid;[4-[6-(2-tert-butyl-4-pyridinyl)-2-pyridinyl]-3-chlorophenyl]-(4-hydroxypiperidin-1-yl)methanone;2-tert-butyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine;(2-chloro-4-formyloxyphenyl)boronic acid;2,6-dibromopyridine;piperidin-4-ol with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-bromo-6-(2-tert-butyl-4-pyridinyl)pyridine;4-[6-(2-tert-butyl-4-pyridinyl)-2-pyridinyl]-3-chlorobenzoic acid;[4-[6-(2-tert-butyl-4-pyridinyl)-2-pyridinyl]-3-chlorophenyl]-(4-hydroxypiperidin-1-yl)methanone;2-tert-butyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine;(2-chloro-4-formyloxyphenyl)boronic acid;2,6-dibromopyridine;piperidin-4-ol?
The IUPAC name of 2-bromo-6-(2-tert-butyl-4-pyridinyl)pyridine;4-[6-(2-tert-butyl-4-pyridinyl)-2-pyridinyl]-3-chlorobenzoic acid;[4-[6-(2-tert-butyl-4-pyridinyl)-2-pyridinyl]-3-chlorophenyl]-(4-hydroxypiperidin-1-yl)methanone;2-tert-butyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine;(2-chloro-4-formyloxyphenyl)boronic acid;2,6-dibromopyridine;piperidin-4-ol (CID 159956586) is 2-bromo-6-(2-tert-butyl-4-pyridinyl)pyridine;4-[6-(2-tert-butyl-4-pyridinyl)-2-pyridinyl]-3-chlorobenzoic acid;[4-[6-(2-tert-butyl-4-pyridinyl)-2-pyridinyl]-3-chlorophenyl]-(4-hydroxypiperidin-1-yl)methanone;2-tert-butyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine;(2-chloro-4-formyloxyphenyl)boronic acid;2,6-dibromopyridine;piperidin-4-ol.
What is the SMILES notation for 2-bromo-6-(2-tert-butyl-4-pyridinyl)pyridine;4-[6-(2-tert-butyl-4-pyridinyl)-2-pyridinyl]-3-chlorobenzoic acid;[4-[6-(2-tert-butyl-4-pyridinyl)-2-pyridinyl]-3-chlorophenyl]-(4-hydroxypiperidin-1-yl)methanone;2-tert-butyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine;(2-chloro-4-formyloxyphenyl)boronic acid;2,6-dibromopyridine;piperidin-4-ol?
The canonical SMILES for 2-bromo-6-(2-tert-butyl-4-pyridinyl)pyridine;4-[6-(2-tert-butyl-4-pyridinyl)-2-pyridinyl]-3-chlorobenzoic acid;[4-[6-(2-tert-butyl-4-pyridinyl)-2-pyridinyl]-3-chlorophenyl]-(4-hydroxypiperidin-1-yl)methanone;2-tert-butyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine;(2-chloro-4-formyloxyphenyl)boronic acid;2,6-dibromopyridine;piperidin-4-ol is Brc1cccc(Br)n1.CC(C)(C)c1cc(-c2cccc(-c3ccc(C(=O)N4CCC(O)CC4)cc3Cl)n2)ccn1.CC(C)(C)c1cc(-c2cccc(-c3ccc(C(=O)O)cc3Cl)n2)ccn1.CC(C)(C)c1cc(-c2cccc(Br)n2)ccn1.CC(C)(C)c1cc(B2OC(C)(C)C(C)(C)O2)ccn1.O=COc1ccc(B(O)O)c(Cl)c1.OC1CCNCC1.
What is the InChIKey of 2-bromo-6-(2-tert-butyl-4-pyridinyl)pyridine;4-[6-(2-tert-butyl-4-pyridinyl)-2-pyridinyl]-3-chlorobenzoic acid;[4-[6-(2-tert-butyl-4-pyridinyl)-2-pyridinyl]-3-chlorophenyl]-(4-hydroxypiperidin-1-yl)methanone;2-tert-butyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine;(2-chloro-4-formyloxyphenyl)boronic acid;2,6-dibromopyridine;piperidin-4-ol?
The InChIKey is OCUGQMRACBJKQO-UHFFFAOYSA-N. The full InChI is InChI=1S/C26H28ClN3O2.C21H19ClN2O2.C15H24BNO2.C14H15BrN2.C7H6BClO4.C5H3Br2N.C5H11NO/c1-26(2,3)24-16-17(9-12-28-24)22-5-4-6-23(29-22)20-8-7-18(15-21(20)27)25(32)30-13-10-19(31)11-14-30;1-21(2,3)19-12-13(9-10-23-19)17-5-4-6-18(24-17)15-8-7-14(20(25)26)11-16(15)22;1-13(2,3)12-10-11(8-9-17-12)16-18-14(4,5)15(6,7)19-16;1-14(2,3)12-9-10(7-8-16-12)11-5-4-6-13(15)17-11;9-7-3-5(13-4-10)1-2-6(7)8(11)12;6-4-2-1-3-5(7)8-4;7-5-1-3-6-4-2-5/h4-9,12,15-16,19,31H,10-11,13-14H2,1-3H3;4-12H,1-3H3,(H,25,26);8-10H,1-7H3;4-9H,1-3H3;1-4,11-12H;1-3H;5-7H,1-4H2.
What are the key properties of 2-bromo-6-(2-tert-butyl-4-pyridinyl)pyridine;4-[6-(2-tert-butyl-4-pyridinyl)-2-pyridinyl]-3-chlorobenzoic acid;[4-[6-(2-tert-butyl-4-pyridinyl)-2-pyridinyl]-3-chlorophenyl]-(4-hydroxypiperidin-1-yl)methanone;2-tert-butyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine;(2-chloro-4-formyloxyphenyl)boronic acid;2,6-dibromopyridine;piperidin-4-ol?
2-bromo-6-(2-tert-butyl-4-pyridinyl)pyridine;4-[6-(2-tert-butyl-4-pyridinyl)-2-pyridinyl]-3-chlorobenzoic acid;[4-[6-(2-tert-butyl-4-pyridinyl)-2-pyridinyl]-3-chlorophenyl]-(4-hydroxypiperidin-1-yl)methanone;2-tert-butyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine;(2-chloro-4-formyloxyphenyl)boronic acid;2,6-dibromopyridine;piperidin-4-ol has a molecular weight of 1907.62 g/mol, XLogP of 19.59, 11 rotatable bonds, 6 hydrogen bond donors, and 19 hydrogen bond acceptors.
Where does this data come from?
All data for 2-bromo-6-(2-tert-butyl-4-pyridinyl)pyridine;4-[6-(2-tert-butyl-4-pyridinyl)-2-pyridinyl]-3-chlorobenzoic acid;[4-[6-(2-tert-butyl-4-pyridinyl)-2-pyridinyl]-3-chlorophenyl]-(4-hydroxypiperidin-1-yl)methanone;2-tert-butyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine;(2-chloro-4-formyloxyphenyl)boronic acid;2,6-dibromopyridine;piperidin-4-ol is sourced from PubChem (CID 159956586), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).